| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0083 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |